ANCA-associated vasculitis trials in Austria

4 of 5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 14 November 2026. Ask the study team whether a trial fits you.

• Phase 3Not yet taking people in Austria
  Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

  Where

  Innsbruck

  Age

  6 years and over

  People

  230 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07444567
• Phase 3Not yet taking people in Austria
  ROSY-F: Roll-over Study for Participants Who Have Completed a Previous Clinical Study with Benralizumab (Fasenra) and Benefit from Continued Treatment

  Where

  Innsbruck

  People

  94 worldwide

  Run by

  AstraZeneca AB

  See details and how to join2025-523307-29-00
• Phase 4Not yet taking people in Austria
  Discontinuation of rituximab compared with rituximab maintenance in ANCA-associated vasculitis – a randomized non-blinded controlled trial (DISRITUX)

  Where

  DO NOT EDIT

  Age

  18 years and over

  People

  130 worldwide

  Run by

  Region Oestergoetland

  See details and how to join2023-508398-10-00
• Phase 4Taking people
  EFFECT OF ONCE VS TWICE DAILY ADMINISTRATION OF CORTICOSTEROIDS ON BLOOD GLUCOSE IN PATIENTS WITH ANCA-VASCULITIS MEASURED BY CONTINUOUS BLOOD GLUCOSE MONITORING - A PILOT STUDY

  Where

  Graz

  Age

  18 years and over

  People

  10

  Run by

  Medical University Of Graz

  See details and how to join2024-516141-39-00